Literature DB >> 24722739

Towards a global framework for capacity building for non-communicable disease advocacy in low- and middle-income countries.

Trevor Shilton1, Beatriz Champagne, Claire Blanchard, Lorena Ibarra, Vijj Kasesmup.   

Abstract

Non-communicable diseases (NCDs) represent an increasing proportion of morbidity and mortality throughout the world. Sustained advocacy, carried out by a skilled workforce, is an important strategy to realize the political will and implement the policy changes necessary to reduce the global burden of NCDs. Competencies for effective advocacy include a combination of scientific and technical as well as communication-based skills. Recognizing the need to build local capacity for NCD advocacy in low- and middle-income countries (LMIC), the International Union for Health Promotion and Education (IUHPE), the US Centers for Disease Control and Prevention (CDC), the National Heart Foundation of Australia and the InterAmerican Heart Foundation joined efforts to conduct two pilot advocacy courses, one in Thailand and one in Colombia. A Global Advisory Group engaged a Local Organizing Committee in each country to ensure the courses would meet the needs of the local stakeholders. While both courses contained a set of key competencies and helped participants develop joint strategies for moving forward with consensus advocacy targets, the courses differed in content and participant background depending on the local context. A key goal of the courses was to determine and describe the lessons learned and make recommendations for a framework to be used for future advocacy capacity-building activities in LMIC. The planning and execution of each course generated lessons in the following five areas that informed the development of a global framework for capacity building for NCD advocacy: 1) using a comprehensive theoretical framework to teach advocacy competencies, 2) engaging key stakeholders, 3) meeting local needs and priorities, 4) planning local logistics, and 5) ensuring the skills obtained through training are applied to sustained advocacy for NCDs.

Entities:  

Keywords:  advocacy; capacity building; low- and middle-income countries; non-communicable disease; training

Mesh:

Year:  2013        PMID: 24722739     DOI: 10.1177/1757975913501208

Source DB:  PubMed          Journal:  Glob Health Promot        ISSN: 1757-9759


  5 in total

1.  Ability of HIV Advocacy to Modify Behavioral Norms and Treatment Impact: A Systematic Review.

Authors:  Bruno F Sunguya; Murallitharan Munisamy; Sathirakorn Pongpanich; Junko Yasuoka; Masamine Jimba
Journal:  Am J Public Health       Date:  2016-06-16       Impact factor: 9.308

Review 2.  A roadmap of strategies to support cardiovascular researchers: from policy to practice.

Authors:  Niamh Chapman; Emma E Thomas; Joanne T M Tan; Sally C Inglis; Jason H Y Wu; Rachel E Climie; Dean S Picone; Lauren C Blekkenhorst; Steven G Wise; Katrina M Mirabito Colafella; Anna C Calkin; Francine Z Marques
Journal:  Nat Rev Cardiol       Date:  2022-05-16       Impact factor: 49.421

3.  "We need more big trees as well as the grass roots": going beyond research capacity building to develop sustainable careers in mental health research in African countries.

Authors:  Lisa F Langhaug; Helen Jack; Charlotte Hanlon; Stefan Holzer; Katherine Sorsdahl; Barbara Mutedzi; Walter Mangezi; Christopher Merritt; Atalay Alem; Robert Stewart; Chiwoza Bandawe; Rosemary Musesengwa; Melanie Abas; Dixon Chibanda; Crick Lund
Journal:  Int J Ment Health Syst       Date:  2020-08-14

Review 4.  A scoping review of non-communicable disease research capacity strengthening initiatives in low and middle-income countries.

Authors:  Tilahun Nigatu Haregu; Allison Byrnes; Kavita Singh; Thirunavukkarasu Sathish; Naanki Pasricha; Kremlin Wickramasinghe; Kavumpurathu Raman Thankappan; Brian Oldenburg
Journal:  Glob Health Res Policy       Date:  2019-11-29

5.  Needs of LMIC-based tobacco control advocates to counter tobacco industry policy interference: insights from semi-structured interviews.

Authors:  Britta Katharina Matthes; Lindsay Robertson; Anna B Gilmore
Journal:  BMJ Open       Date:  2020-11-26       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.